Visalytics
Visalytics
approved EB-2 (NIW)

Visiting Researcher

Cancer Pathology · Japan · 2025-04-01

Processing Time
54 days
Decision Date
2025-04-01
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop advanced diagnostic and therapeutic approaches for cancer through biomarker identification and optimized combination therapies. This work focuses on enhancing early detection, personalizing treatment plans, and improving survival outcomes for cancer patients within the biotech and pharmaceutical industry.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses cancer, a leading cause of death, and supports the U.S. cancer therapeutics market projected to reach $120 billion.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a strong publication record, significant citation impact, and has received funding from prestigious Japanese government organizations.

3 Balance of Interests Met

The petitioner's contributions to early detection and precision medicine provide a clear benefit to U.S. public health that outweighs the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 11 peer-reviewed journal articles and 13 first-authored conference abstracts which garnered 131 citations. Evidence included 3 completed peer reviews, research funding from the Japan Society for the Promotion of Science (JSPS), and publication in high-impact journals like Acta Neuropathologica Communications. All three Dhanasar prongs were satisfied through documentation of national importance and the petitioner's established expertise.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Conference Presentations
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Project Manager

Biotechnology · India

WeGreened EB-2 (NIW) approved
Alabama 26 days 2024-12-02
The petitioner plans to develop precision biomarker oncology tests for biopsy samples to advance clinical cancer trials and drug development. Her work focuses on elucidating unique characteristics of cancer cells to establish therapeutic targets for precision medicine.
View Case

Doctor

Healthcare · China

WeGreened EB-2 (NIW) rfe approved
169 days 2025-06-11
The petitioner proposes to continue his work in personalized oncology by developing tailored treatment regimens based on molecular diagnostics and tumor genomics. His research focuses on refining patient stratification to enable more effective and less toxic cancer therapies.
View Case

Others

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 464 days 2022-05-21
The petitioner proposes to continue the full characterization of cellular and genetic mechanisms related to cancers that interact with their surrounding microenvironment. The work focuses on improving treatment strategies, identifying therapeutic targets to slow metastasis, and mitigating the economic costs associated with cancer care.
View Case

Others

Biotechnology · Malaysia

WeGreened EB-2 (NIW) approved
Florida 170 days 2022-03-05
The petitioner proposes to continue investigating the underlying biology of cancer and establishing key biomarkers. This work aims to enhance patient outcomes through early detection and the development of targeted treatments.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Japan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-01.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 54 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Japan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist